Cabaletta Bio Inc Cash Flow-to-Debt Ratio
Cabaletta Bio Inc cash flow-to-debt ratio. Cabaletta Bio Inc (CABA) has a Cash Flow-to-Debt Ratio of -0.90x as of June 2026, meaning its operating cash flow of $-41.51 Million could theoretically repay -1% of its total liabilities ($46.13 Million) in one year. See Cabaletta Bio Inc (CABA) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Cabaletta Bio Inc (2017–2025)
Cash flow-to-debt ratio of Cabaletta Bio Inc from 2017 to 2025. Historical debt coverage capacity for Cabaletta Bio Inc across 9 annual periods. Also explore Cabaletta Bio Inc (CABA) net asset momentum to track the company's year-over-year net asset growth rate.
Cabaletta Bio Inc Cash Flow-to-Debt Ratio by Year (2017–2025)
Cabaletta Bio Inc cash flow-to-debt ratio by year from 2017 to 2025. Year-by-year debt coverage analysis for Cabaletta Bio Inc. For the full cash flow conversion analysis, see Cabaletta Bio Inc (CABA) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.47x | $-131.08 Million | $53.03 Million | ▲ +8.4% |
| 2024 | -2.70x | $-88.22 Million | $32.71 Million | ▲ +12.1% |
| 2023 | -3.07x | $-53.55 Million | $17.45 Million | ▲ +17.6% |
| 2022 | -3.73x | $-46.38 Million | $12.45 Million | ▲ +8.5% |
| 2021 | -4.07x | $-34.11 Million | $8.38 Million | ▲ +21.2% |
| 2020 | -5.17x | $-26.77 Million | $5.18 Million | ▼ -1.4% |
| 2019 | -5.10x | $-16.05 Million | $3.15 Million | ▼ -4807.5% |
| 2018 | -0.10x | $-4.66 Million | $44.86 Million | ▲ +99.4% |
| 2017 | -18.64x | $-4.66 Million | $250.00K | — |